---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-006441"
form_type: "8-K/A"
ticker: "XBIT"
cik: "0001626878"
company_name: "XBiotech Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:44:25.589019+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# XBiotech amends director bio: Rademaker is consultant to multiple PE firms

## Summary
- Clarifies Craig Rademaker is a consultant to several Canadian private equity firms, not a single firm.
- His responsibilities principally include capital markets activities.
- No change to his role as director or any compensatory arrangements.
- Amendment corrects prior 8-K filed June 24, 2025, for Item 5.02.

## SEC filing metadata
- accession: 0001171843-25-006441
- form_type: 8-K/A
- ticker: XBIT
- cik: 0001626878
- company_name: XBiotech Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626878/000117184325006441/0001171843-25-006441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626878/000117184325006441/f8ka_101525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-006441
- JSON: https://secwatch.observer/filing/0001171843-25-006441.json
- Plain text: https://secwatch.observer/filing/0001171843-25-006441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.